TWiV 889: COVID-19 clinical update #110 with Dr. Daniel Griffin
Apr 16, 2022•53 min•Ep. 889
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #110, Dr. Griffin covers hospital admissions during variant outbreaks, viral load in vaccinated and unvaccinated individuals, predictive capacity of symptoms in children, comparison of antigen tests, incidence of myocarditis after vaccination, steroids during replication phase, Paxlovid efficacy and safety, fluvoxamine, sabizabutin, colchicine, and prevalence of infection in Africa.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Hospital admissions during Omicron and Delta variant outbreaks (Lancet)
- Viral load in unvaccinated and vaccinated individuals (Nat Med)
- Predictive Capability of symptoms in children (Clin Inf Dis)
- Comparison of antigen tests (medRxiv)
- Incidence of Myocarditis after COVID19 and non-COVID19 vaccination (Lancet)
- Steroids during viral replication phase (Resp)
- Paxlovid efficacy and safety (Pfizer)
- Fluvoxamine & Outpatient Management (JAMA)
- Sabizabutin efficacy and safety (Veru)
- Colchicine and lack of benefit (Lancet)
- SARS-CoV-2 prevalence in Africa (medRxiv)
- Contribute to ASTMH fundraiser at PWB
- Dr. Griffin's treatment guide (pdf)
- Letters read on TWiV 889 33:35
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android